OW 2025 4 - 7 November 2025

Effect of Semaglutide 2.4 mg in Chinese Adults With Overweight or Obesity (BMI ≥24 or ≥28): STEP 12

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress oral presentation
GLP-1 RA
Semaglutide
PHASE 3 (RCT)